FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.72B
1-Year Est. Return 129.71%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+129.71%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.34B
AUM Growth
+$837M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
53
New
Increased
Reduced
Closed

Top Buys

1
+$23.2M
2
+$14.5M
3
+$13.8M
4
DYN icon
Dyne Therapeutics
DYN
+$13.8M
5
ZLAB icon
Zai Lab
ZLAB
+$11M

Top Sells

1
+$21.1M
2
+$20M
3
+$12.9M
4
COGT icon
Cogent Biosciences
COGT
+$12.5M
5
TVTX icon
Travere Therapeutics
TVTX
+$11.5M

Sector Composition

1 Healthcare 99.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VALN
26
Valneva
VALN
$963M
$28M 0.84%
2,291,666
+833,333
RNAM
27
Avidity Biosciences
RNAM
$11.2B
$27.2M 0.82%
625,000
ASND icon
28
Ascendis Pharma
ASND
$14.3B
$26.5M 0.79%
133,333
ALKS icon
29
Alkermes
ALKS
$4.98B
$21M 0.63%
700,647
-300,000
MREO
30
Mereo BioPharma
MREO
$63.8M
$19.4M 0.58%
9,440,112
AKRO
31
DELISTED
Akero Therapeutics
AKRO
$17.4M 0.52%
366,784
PCVX icon
32
Vaxcyte
PCVX
$8.89B
$17.1M 0.51%
474,405
EOLS icon
33
Evolus
EOLS
$280M
$16.2M 0.48%
2,630,665
+195,115
DSGN icon
34
Design Therapeutics
DSGN
$581M
$14.7M 0.44%
1,953,547
IMCR icon
35
Immunocore
IMCR
$1.67B
$14M 0.42%
384,782
ACAD icon
36
Acadia Pharmaceuticals
ACAD
$3.93B
$13.1M 0.39%
+613,837
JBIO
37
Jade Biosciences
JBIO
$695M
$12.2M 0.37%
1,413,280
-358,836
ASMB icon
38
Assembly Biosciences
ASMB
$471M
$11.7M 0.35%
+456,249
ADVM
39
DELISTED
Adverum Biotechnologies
ADVM
$9.41M 0.28%
2,077,431
+1,008,187
TVTX icon
40
Travere Therapeutics
TVTX
$2.65B
$9.37M 0.28%
392,092
-610,000
NAMSW icon
41
NewAmsterdam Pharma Warrant
NAMSW
$8.56M 0.26%
500,333
ENGN icon
42
enGene Holdings
ENGN
$678M
$7.9M 0.24%
+1,157,380
AUTL
43
Autolus Therapeutics
AUTL
$452M
$7.54M 0.23%
4,623,324
MGNX icon
44
MacroGenics
MGNX
$127M
$5.34M 0.16%
3,175,665
SLN
45
Silence Therapeutics
SLN
$297M
$5.03M 0.15%
970,130
ALLO icon
46
Allogene Therapeutics
ALLO
$600M
$4.8M 0.14%
3,868,750
CBIO
47
Crescent Biopharma
CBIO
$350M
$3.25M 0.1%
272,951
-180,734
CGON icon
48
CG Oncology
CGON
$4.86B
– –
-770,000
ELEV
49
DELISTED
Elevation Oncology
ELEV
– –
-5,993,579
HLVX
50
DELISTED
HilleVax
HLVX
– –
-10,617,062
1
2
3